Back

Amiloride HCl Dihydrate in coronary artery disease: improving erythrocyte potassium-oxigen binding and reversion of angina and ST-T alterations.

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Stable CAD Angina pectoris stable ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Carlos Delgado

University of Carabobo, Valencia (Venezuela (Bolivarian Republic of))

69 More presentations in this session

Presentation thumbnail
Comparison of renal outcome with renote ischemic preconditioning versus nicorandil following percutaneous coronary intervention in stable angina patients; results from the RINC trial
Doctor T. Yamanaka (Tsuyama, JP)
Abstract Slides
Presentation thumbnail
Expression of miR-23a induces leukocyte telomere shortening and is associated with poor clinical outcomes in patients with coronary artery disease
Doctor T. Nasu (Yahaba, JP)
Abstract Slides
Presentation thumbnail
Lectin-like oxidized low density lipoprotein receptor-1 exhibits increased expression in the epicardial coronary arteries in patients with coronary artery disease. The intramyocardial paradox
Doctor A. Synetos (Athens, GR)
Abstract
Presentation thumbnail
Appropriateness of percutaneous coronary interventions in patients with ischemic heart disease in Italy: The APACHE Pilot study
Associate Professor S. Leonardi (Pavia, IT)
Abstract Slides
Presentation thumbnail
Adherence to therapy based on core cognitive domains in patients with coronary artery disease
Doctor O. Maleva (Kemerovo, RU)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Stable CAD

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources